Amid pomp and pageantry not seen for more than half a century, King Charles and Queen Camilla arrived at Canada 's Parliament ...

CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of ...

All Common Shares purchased by the Company under the NCIB will be cancelled. Management of Black Diamond believes that, from time to time, the market price of the Common Shares may not fully reflect ...

CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) — Black Diamond Group Limited (TSX: BDI, OTCQX:BDIMF) (“Black Diamond” or the “Company”) announces that it has obtained approval of the ...

Perhaps unsurprisingly to many, the first signs of an answer are emerging in the outdoor industry. Today, Black Diamond Equipment issued a statement on their social media and in an email newsletter ...

BLACK DIAMOND, Wash. — A man in his 60s was discovered unresponsive in the water at Black Diamond Lake, according to the Black Diamond Police Department. The BDPD confirmed the incident on ...

The official statement from the network read, “Rebecca Sugar confirms new Steven Universe series about Diamonds, with focus on new character “Black Diamond.” Unfortunately, fans’ hopes ...

In North America, ski resorts use the following system to identify the difficulty of each slope (trail types are listed in ascending order of difficulty): The term 'black diamond' seems to have ...

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported a significant stock sale by BB Biotech AG, as revealed in a recent SEC filing. On March 19, BB Biotech AG sold a total of 5,784,292 shares ...

Shares of Black Diamond Therapeutics rose sharply in premarket trading Wednesday after the clinical-stage oncology company said it inked a licensing agreement potentially worth hundreds of ...

Under the agreement, Servier will develop and commercialize BDTX-4933, a small molecule designed by Black Diamond Therapeutics for RAF/RAS-mutant solid tumors. Under the terms of the deal ...

Black Diamond Therapeutics has found a partner for its deprioritized solid tumor candidate. Five months after cutting support for BDTX-4933, the biotech has licensed the RAF inhibitor to Servier ...